CN Patent

CN114615982A — 用于治疗胃肠道间质瘤的瑞普替尼

Assigned to Deciphera Pharmaceuticals LLC · Expires 2022-06-10 · 4y expired

What this patent protects

本公开涉及一种治疗有需要的受试者的胃肠道间质瘤的方法，包括向所述受试者施用治疗有效量的瑞普替尼或其药学上可接受的盐。

USPTO Abstract

本公开涉及一种治疗有需要的受试者的胃肠道间质瘤的方法，包括向所述受试者施用治疗有效量的瑞普替尼或其药学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number: CN114615982A
Jurisdiction: CN
Classification: —
Expires: 2022-06-10
Drug substance claim: No
Drug product claim: No
Assignee: Deciphera Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.